Amgen Announces Phase 2 Study Results for Brodalumab in Moderate to Severe Plaque Psoriasis Published in the New England Journal of Medicine Read more about Amgen Announces Phase 2 Study Results for Brodalumab in Moderate to Severe Plaque Psoriasis Published in the New England Journal of Medicine
Amgen's PCSK9 Inhibitor Reduced LDL Cholesterol up to 81 Percent in Phase 1b Study Read more about Amgen's PCSK9 Inhibitor Reduced LDL Cholesterol up to 81 Percent in Phase 1b Study
Amgen Announces 2012 Second Quarter Dividend Read more about Amgen Announces 2012 Second Quarter Dividend
Amgen Completes Tender Offer for Outstanding Shares of Micromet, Inc. Read more about Amgen Completes Tender Offer for Outstanding Shares of Micromet, Inc.
Amgen Announces Initial Results of Tender Offer for Outstanding Shares of Micromet, Inc. and Commencement of Subsequent Offering Period Read more about Amgen Announces Initial Results of Tender Offer for Outstanding Shares of Micromet, Inc. and Commencement of Subsequent Offering Period
Schwartz Center Receives $500,000 Grant from the Amgen Foundation Read more about Schwartz Center Receives $500,000 Grant from the Amgen Foundation
Amgen to Present at the Cowen and Company 32nd Annual Healthcare Conference Read more about Amgen to Present at the Cowen and Company 32nd Annual Healthcare Conference
Amgen and European Schoolnet Launch New Professional Development Initiative for Life Science Teachers Read more about Amgen and European Schoolnet Launch New Professional Development Initiative for Life Science Teachers
Amgen to Present at the Citi 2012 Global Healthcare Conference Read more about Amgen to Present at the Citi 2012 Global Healthcare Conference
CURE Magazine Teams up with Amgen Oncology and Breakaway from Cancer® to Launch 2012 Extraordinary Healer Award for Oncology Nursing Read more about CURE Magazine Teams up with Amgen Oncology and Breakaway from Cancer® to Launch 2012 Extraordinary Healer Award for Oncology Nursing
